Summit Investment Advisors Inc. Has $756,000 Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Summit Investment Advisors Inc. decreased its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 4.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 39,815 shares of the medical instruments supplier’s stock after selling 1,774 shares during the quarter. Summit Investment Advisors Inc.’s holdings in DENTSPLY SIRONA were worth $756,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in XRAY. Riverview Trust Co bought a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at about $26,000. MassMutual Private Wealth & Trust FSB boosted its position in DENTSPLY SIRONA by 648.4% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 1,232 shares during the last quarter. UMB Bank n.a. grew its stake in DENTSPLY SIRONA by 60.8% in the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock valued at $28,000 after purchasing an additional 564 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of DENTSPLY SIRONA by 700.0% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier’s stock worth $33,000 after purchasing an additional 1,568 shares during the last quarter. Finally, Signaturefd LLC raised its stake in shares of DENTSPLY SIRONA by 513.3% during the 4th quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier’s stock worth $84,000 after purchasing an additional 3,706 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Mizuho decreased their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating for the company in a research report on Thursday, March 13th. Evercore ISI reaffirmed an “in-line” rating and issued a $20.00 target price on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Jefferies Financial Group downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and cut their target price for the company from $30.00 to $20.00 in a research note on Thursday, January 23rd. Finally, Wells Fargo & Company cut their price objective on DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating for the company in a research report on Friday, February 28th. Thirteen investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, DENTSPLY SIRONA presently has a consensus rating of “Hold” and a consensus target price of $22.58.

DENTSPLY SIRONA Stock Up 1.4 %

NASDAQ:XRAY opened at $12.83 on Friday. DENTSPLY SIRONA Inc. has a one year low of $12.16 and a one year high of $31.00. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The company has a market cap of $2.56 billion, a PE ratio of -6.20, a P/E/G ratio of 1.80 and a beta of 0.92. The firm’s 50 day simple moving average is $15.83 and its 200 day simple moving average is $18.92.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were issued a $0.16 dividend. The ex-dividend date was Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a yield of 4.99%. DENTSPLY SIRONA’s payout ratio is -14.07%.

Insider Buying and Selling

In related news, Director Gregory T. Lucier purchased 15,142 shares of the firm’s stock in a transaction dated Monday, March 3rd. The stock was bought at an average price of $16.51 per share, with a total value of $249,994.42. Following the completion of the purchase, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. 0.52% of the stock is owned by corporate insiders.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.